TEVA tops ENDP's buyout bid for PATH: http://www.fiercebiotech.com/story/troubled-teva-offers-surprise-rival-bid-nupathe/2014-01-08 Until this is resolved, I'm removing PATH from the table of biotech buyouts kept in the iBox of this message board.